Below you will find the articles on economics, investing, and finance that we found most interesting for the week.
NB: ($) denotes subscription site.
Price increases for MS drugs have been amazing even as new drugs have come to market.
Japan has historically been the place where activists go to lose. Not anymore; Dan Loeb succeeds in making Fanuc more shareholder-friendly.
Consolidation is the topic du jour in biotech, why not agricultural biotech? Monsanto (re)considers a bid for Syngenta.
Is lack of liquidity in the bond markets a potential crisis on the horizon? ETFs with daily liquidity that invest in illiquid levered loans sound like a setup for potential problems if you ask us.
Own Chinese stocks with a VIE structure (that includes almost all the major Chinese Internet companies)? You might want to consider what happens when the Chinese government declares your corporate structure illegal.